Annual Minimums. The following Annual Minimums must be paid during the Term of the Agreement, which has been extended to include Deferred Compensation Annual Minimum Payments: Annual Period Annual Minimum Year 1 (Effective Date through 12/31/2014) $ 0 Year 2 (2015 β Due 12/31/2015) through Year 6 (2020 β Due 12/31/2020) $ 100,000 Year 7 and every year thereafter that there is no market approval from the US FDA or a foreign equivalent $ 0 The first year with a market approval from the US FDA or a foreign equivalent and every year thereafter until the first commercial sale of a Product $ 350,000 The first year with a commercial sale of a Product and every year thereafter $ 400,000 The following one-time Milestone payments must be paid during the Term of the Agreement, which has been extended in accordance with Section 3.4 and may be treated as Deferred Compensation.
Appears in 3 contracts
Sources: Stock Transfer Agreement (RespireRx Pharmaceuticals Inc.), Sublicense Agreement (RespireRx Pharmaceuticals Inc.), Exclusive License Agreement (RespireRx Pharmaceuticals Inc.)